Free Consultation • Available 24/7
The current FDA label tells providers to discontinue Depo-Provera if a patient is diagnosed with meningioma. A diagnosis after long-term use may raise important questions.
Depo-Provera is an injectable birth control medication. Many women used it for years because it was effective and convenient. Recent research has raised questions about whether long-term use may increase the risk of meningioma. A meningioma is a tumor that develops in the tissue surrounding the brain or spinal cord. Depending on its size and location, it may require monitoring, surgery, radiation, or other treatment.
Not every Depo-Provera user will develop a tumor. The FDA’s current Depo-Provera label states that meningioma cases have been reported after repeated use, primarily with long-term use. It directs health care providers to monitor for symptoms and discontinue Depo-Provera if a meningioma is diagnosed.
A diagnosis alone does not determine whether someone has a legal claim. A case review should consider the type of Depo-Provera used, the length of use, the date of diagnosis, available medical records, and the treatment required. Injection and pharmacy records, imaging reports, surgical records, and pathology reports can help establish the history of a case.
Depo-Provera cases are currently proceeding in federal court. Plaintiffs allege that the manufacturers failed to provide adequate warnings. The defendants dispute those allegations and maintain that the medication is safe and effective.
Berry Law reviews cases for people who received Depo-Provera or a generic equivalent and were later diagnosed with meningioma. We identify the records needed for a case evaluation, explain the process clearly, and determine whether a claim may be available.
The core legal claims rest on the allegation that Pfizer and its subsidiaries failed to adequately warn patients and healthcare providers about the serious health risks linked to long-term use of the drug. A major scientific study published in 2024 revealed that women using Depo-Provera for extended periods faced an increased risk of developing a meningioma, which is a tumor that forms on the membranes covering the brain and spinal cord. Plaintiffs argue that the manufacturer knew or should have known about the potential hormonal interactions causing these tumors, but prioritized marketing over safety. By failing to include clear warnings on the product labeling, the company deprived women of the ability to make fully informed choices regarding their contraceptive care and long-term health options.
While meningiomas aren’t always cancerous, their growth can place dangerous pressure on the surrounding brain tissue, blood vessels, and nerves. This localized pressure can lead to severe and life-altering neurological symptoms. Many women affected by these tumors report experiencing chronic and worsening headaches, sudden vision changes such as double vision or blurring, hearing loss, or ringing in the ears. Other common warning signs include memory issues, loss of smell, unexplained seizures, and weakness or numbness in the limbs. If you have a history of using Depo-Provera and have experienced any of these symptoms, it is vital to seek immediate medical evaluation. A proper diagnosis via an MRI or CT scan is the first step toward addressing the health impact and establishing a foundation for any future legal claim.
Eligibility for a mass tort claim depends on specific usage and medical criteria. Currently, the litigation focuses on individuals who can document that they received at least two injections of brand-name Depo-Provera, Depo-SubQ Provera, or an authorized generic variant manufactured by approved pharmaceutical companies like Greenstone or Pharmacia & Upjohn. In addition to proving a history of usage, a qualifying plaintiff must have received a formal medical diagnosis of a meningioma or another qualified benign brain tumor after using the contraceptive. Because legal timelines and statutes of limitations restrict how long a victim can wait before taking legal action, it is highly recommended to have your case reviewed by a qualified personal injury attorney as soon as possible after receiving a diagnosis to protect your right to compensation.
When a commercial drug or product harms thousands of people in a similar way, the legal system often groups these individual cases into a mass tort or Multidistrict Litigation (MDL). Unlike a traditional class-action lawsuit where a single verdict applies to an entire group equally, a mass tort allows each plaintiff to maintain their individual lawsuit. This framework allows independent lawyers to pool resources and investigate the manufacturer's corporate files collectively, which dramatically levels the playing field against massive pharmaceutical corporations. If a global settlement is reached or individual bellwether trials succeed, compensation is distributed to each plaintiff based on the unique physical, emotional, and financial damage they sustained, covering everything from past surgical expenses to long-term diminished quality of life.
Practical tools and clear information to help you understand your legal options. Explore Berry Law articles, videos, and calculators for Veterans, injured people, and their families.
Get a free review of your case from our personal injury attorneys.
A strong claim starts with the facts and follows the evidence. Berry Law handles the legal work so you can focus on your recovery.
We review your case at no cost and explain your options.
You can call us 24/7.
We gather evidence, obtain medical records, interview witnesses and build your case.
We negotiate aggressively with insurance companies to get you fair compensation.
We settle your case or take it to trial if the insurance company will not pay fairly.
Contact our personal injury attorneys today for a free consultation. We understand what you're going through and will fight for the compensation you're entitled to.
